Sonnet BioTherapeutics (SONN) Earnings Date, Estimates & Call Transcripts → 348 million Americans lives to END as we know it? (From The Oxford Club) (Ad) Free SONN Stock Alerts Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryLatest Earnings DateFeb. 14EstimatedActual EPS (Feb. 14) -$0.31 Missed By -$0.31 Get Sonnet BioTherapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for SONN and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueSONN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SONN Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. Sonnet BioTherapeutics Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($2.27) EPSSONN Earnings Date and InformationSonnet BioTherapeutics last announced its earnings data on February 14th, 2024. The reported ($0.31) earnings per share for the quarter. The business had revenue of $0.02 million for the quarter. Sonnet BioTherapeutics has generated $0.00 earnings per share over the last year. Read More Sonnet BioTherapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript2/14/2024Q1 2024-($0.31)($0.31)($0.31)-$0.02 million8/14/2023Q3 2023-($2.86)($2.86)($0.13)-$0.04 million5/10/2023Q2 2023-($7.48)($7.48)($0.34)-$0.04 million2/13/2023Q1 2023($24.20)($17.60)+$6.60($0.80)-$0.04 million8/15/2022Q3 2022-($40.04)($40.04)($0.13)-$0.06 million5/10/2022Q2 2022-($43.12)($43.12)($0.14)-$0.10 million Get the Latest News and Ratings for SONN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sonnet BioTherapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/8/2022Q1 2022($92.40)($30.80)+$61.60($0.10)-$0.13 million8/16/2021Q3 2021-($83.16)($83.16)($0.27)--5/17/2021Q2 2021-($98.56)($98.56)($0.32)-- Sonnet BioTherapeutics Earnings - Frequently Asked Questions When did Sonnet BioTherapeutics announce their last quarterly earnings? Sonnet BioTherapeutics (NASDAQ:SONN) last announced its quarterly earning data on Wednesday, February 14, 2024. Learn more on SONN's earnings history. How much revenue does Sonnet BioTherapeutics generate each year? Sonnet BioTherapeutics (NASDAQ:SONN) has a recorded annual revenue of $150,000.00. How much profit does Sonnet BioTherapeutics generate each year? Sonnet BioTherapeutics (NASDAQ:SONN) has a recorded net income of -$18.83 million. SONN has generated $0.00 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: First Wave BioPharma Earnings Results PaxMedica Earnings Results Synaptogenix Earnings Results iBio Earnings Results Hoth Therapeutics Earnings Results Alzamend Neuro Earnings Results Kintara Therapeutics Earnings Results Protagenic Therapeutics Earnings Results Kineta Earnings Results Cingulate Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:SONN) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithDems have chosen Biden replacement?Paradigm Press348 million Americans lives to END as we know it?The Oxford ClubGold Set to EXPLODE!Gold Safe ExchangeObama’s Forever Term [exposed]Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sonnet BioTherapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
